Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine

NCT: NCT05738213 · ACTIVE_NOT_RECRUITING

NCT IDNCT05738213
StatusACTIVE_NOT_RECRUITING
Start Date2023-01-10
Completion2028-01-01
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research study is to investigate the relationships between sex hormone levels and experimental pain sensitivity and migraine severity will be examined.

Frequently Asked Questions

What is Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine?

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine is a clinical trial registered under NCT05738213. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05738213?

The current status of NCT05738213 (Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine) is: ACTIVE_NOT_RECRUITING.

When did Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine start?

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine started on 2023-01-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑